BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21898071)

  • 1. Dysregulated expression of dicer and drosha in breast cancer.
    Yan M; Huang HY; Wang T; Wan Y; Cui SD; Liu ZZ; Fan QX
    Pathol Oncol Res; 2012 Apr; 18(2):343-8. PubMed ID: 21898071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.
    Guo X; Liao Q; Chen P; Li X; Xiong W; Ma J; Li X; Luo Z; Tang H; Deng M; Zheng Y; Wang R; Zhang W; Li G
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):49-56. PubMed ID: 21953080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicer, Drosha, and outcomes in patients with ovarian cancer.
    Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
    N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.
    Avery-Kiejda KA; Braye SG; Forbes JF; Scott RJ
    BMC Cancer; 2014 Apr; 14():253. PubMed ID: 24725360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity in regulation of microRNA machinery components in invasive breast carcinoma.
    Kwon SY; Lee JH; Kim B; Park JW; Kwon TK; Kang SH; Kim S
    Pathol Oncol Res; 2014 Jul; 20(3):697-705. PubMed ID: 24574065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
    Vaksman O; Hetland TE; Trope' CG; Reich R; Davidson B
    Hum Pathol; 2012 Nov; 43(11):2062-9. PubMed ID: 22647351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
    Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
    Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
    Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
    Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Dicer expression in cervical cancer tissues.
    Zhao H; Jin X; Su H; Deng X; Fang Y; Shen L; Xie C
    Med Oncol; 2014 May; 31(5):937. PubMed ID: 24676997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.
    Vincenzi B; Zoccoli A; Schiavon G; Iuliani M; Pantano F; Dell'aquila E; Ratta R; Muda AO; Perrone G; Brunelli C; Correale P; Riva E; Russo A; Loupakis F; Falcone A; Santini D; Tonini G
    Eur J Cancer; 2013 Apr; 49(6):1501-8. PubMed ID: 23266047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated expression of Dicer in invasive ductal breast carcinoma.
    Poursadegh Zonouzi AA; Nejatizadeh A; Rahmati-Yamchi M; Fardmanesh H; Shakerizadeh S; Poursadegh Zonouzi A; Nejati-Koshki K; Shekari M
    Med Oncol; 2015 Jul; 32(7):203. PubMed ID: 26076803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.
    Dedes KJ; Natrajan R; Lambros MB; Geyer FC; Lopez-Garcia MA; Savage K; Jones RL; Reis-Filho JS
    Eur J Cancer; 2011 Jan; 47(1):138-50. PubMed ID: 20832293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.
    Torres A; Torres K; Paszkowski T; Jodłowska-Jędrych B; Radomański T; Książek A; Maciejewski R
    Tumour Biol; 2011 Aug; 32(4):769-76. PubMed ID: 21559780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
    Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
    Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma.
    Zhang Z; Zhang G; Kong C; Bi J; Gong D; Yu X; Shi D; Zhan B; Ye P
    Tumour Biol; 2015 Jul; 36(7):5071-9. PubMed ID: 25656609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Dicer and Drosha in triple-negative breast cancer.
    Passon N; Gerometta A; Puppin C; Lavarone E; Puglisi F; Tell G; Di Loreto C; Damante G
    J Clin Pathol; 2012 Apr; 65(4):320-6. PubMed ID: 22259182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.
    Papachristou DJ; Korpetinou A; Giannopoulou E; Antonacopoulou AG; Papadaki H; Grivas P; Scopa CD; Kalofonos HP
    Virchows Arch; 2011 Oct; 459(4):431-40. PubMed ID: 21769619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript Level of MicroRNA Processing Elements in Gastric Cancer.
    Asadi M; Shanehbandi D; Zafari V; Khaze V; Somi MH; Hashemzadeh S
    J Gastrointest Cancer; 2019 Dec; 50(4):855-859. PubMed ID: 30168106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.
    Lin RJ; Lin YC; Chen J; Kuo HH; Chen YY; Diccianni MB; London WB; Chang CH; Yu AL
    Cancer Res; 2010 Oct; 70(20):7841-50. PubMed ID: 20805302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.